These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8140382)

  • 21. Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients.
    Lacroix JS; Mosimann BL
    J Allergy Clin Immunol; 1996 Sep; 98(3):611-6. PubMed ID: 8828539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge.
    Ciprandi G; Cirillo I; Vizzaccaro A
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):146-50. PubMed ID: 15180356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of TNFalpha on the human nasal mucosa in vivo.
    Widegren H; Korsgren M; Andersson M; Greiff L
    Respir Med; 2007 Sep; 101(9):1982-7. PubMed ID: 17532197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of intranasal triamcinolone acetonide on bronchial hyper-responsiveness in children with seasonal allergic rhinitis and comparison of perceptional nasal obstruction with acoustic rhinometric assessment.
    Oztürk F; Türktaş I; Asal K; Ileri F; Münevver Pinar N
    Int J Pediatr Otorhinolaryngol; 2004 Aug; 68(8):1007-15. PubMed ID: 15236886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
    Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
    Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis.
    Ahlström-Emanuelsson C; Andersson M; Persson C; Schrewelius C; Greiff L
    Clin Exp Allergy; 2004 May; 34(5):731-5. PubMed ID: 15144464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of sphingosine 1-phosphate receptor expression in eosinophils of patients with allergic rhinitis, and effect of topical nasal steroid treatment on this receptor expression.
    Mackle T; Gendy SS; Walsh M; McConn-Walsh R; Costello RW; Walsh MT
    J Laryngol Otol; 2008 Dec; 122(12):1309-17. PubMed ID: 18808729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of intranasal azelastine, Rhinolast, on nasal airways obstruction and sneezing following provocation testing with histamine and allergen.
    Thomas KE; Ollier S; Ferguson H; Davies RJ
    Clin Exp Allergy; 1992 Jun; 22(6):642-7. PubMed ID: 1393763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anterior rhinomanometry in nasal allergen challenges.
    Ferreira MB; Carlos AG
    Allerg Immunol (Paris); 1998 Nov; 30(9):295-7. PubMed ID: 9887989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit.
    Krug N; Hohlfeld JM; Geldmacher H; Larbig M; Heermann R; Lavallee N; Nguyen DT; Petzold U; Hermann R
    Allergy; 2005 Mar; 60(3):354-9. PubMed ID: 15679722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of allergen provocation on the nasal cycle estimated by acoustic rhinometry.
    Kim JK; Cho JH; Jang HJ; Shim DB; Shin HA
    Acta Otolaryngol; 2006 Apr; 126(4):390-5. PubMed ID: 16608791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nasal treatment with a microemulsion reduces allergen challenge-induced symptoms and signs of allergic rhinitis.
    Andersson M; Greiff L; Wollmer P
    Acta Otolaryngol; 2008 Jun; 128(6):666-9. PubMed ID: 18568502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of terfenadine on unilateral nasal challenge with allergen.
    Wagenmann M; Baroody FM; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
    J Allergy Clin Immunol; 1994 Mar; 93(3):594-605. PubMed ID: 7512101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concentrations of chemical mediators in nasal secretions after nasal allergen challenges in atopic patients.
    Wang D; Clement P; Smitz J; Derde MP
    Eur Arch Otorhinolaryngol; 1995; 252 Suppl 1():S40-3. PubMed ID: 7734974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge.
    Wagenmann M; Schumacher L; Bachert C
    Allergy; 2005 Sep; 60(9):1132-8. PubMed ID: 16076297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasal challenge with allergen leads to maxillary sinus inflammation.
    Baroody FM; Mucha SM; Detineo M; Naclerio RM
    J Allergy Clin Immunol; 2008 May; 121(5):1126-1132.e7. PubMed ID: 18367240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of hydroxyzine and phenylpropanolamine in the challenged allergic nose.
    Brooks CD; Nelson A; Parzyck R; Maile MH
    Ann Allergy; 1981 Nov; 47(5 Pt 1):316-9. PubMed ID: 7316247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of the blood flow of the nasal mucosa by the hydrogen clearance method.
    Tanimoto H; Okuda M; Yagi T; Ohtsuka H
    Rhinology; 1983 Mar; 21(1):59-65. PubMed ID: 6190210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reflex activation in allergen-induced nasal mucosal vascular reactions.
    Holmberg K; Bake B; Pipkorn U
    Acta Otolaryngol; 1989; 108(1-2):130-5. PubMed ID: 2763831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.